Daiken Medical Co., Ltd. (TYO:7775)

Daiken Medical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	2,435	2,778	2,995	2,739	2,516	2,518
Cash & Short-Term Investments	2,435	2,778	2,995	2,739	2,516	2,518
Cash Growth	-2.56%	-7.25%	9.35%	8.86%	-0.08%	16.04%
Receivables	2,447	2,570	2,471	2,479	2,530	2,431
Inventory	1,720	1,591	1,430	1,438	1,514	1,544
Prepaid Expenses	-	30	42	24	18	19
Other Current Assets	159	59	47	50	60	60
Total Current Assets	6,761	7,028	6,985	6,730	6,638	6,572
Property, Plant & Equipment	4,013	4,043	3,931	3,986	4,070	4,119
Long-Term Investments	66	67	68	70	65	53
Other Intangible Assets	29	22	12	13	9	15
Long-Term Deferred Tax Assets	205	205	183	205	230	160
Other Long-Term Assets	2	1	2	2	1	1
Total Assets	11,076	11,366	11,181	11,006	11,013	10,920

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	717	676	1,027	1,066	1,117	1,004
Accrued Expenses	166	76	69	65	70	70
Short-Term Debt	920	939	746	1,114	1,058	1,019
Current Portion of Long-Term Debt	435	470	480	389	659	597
Current Portion of Leases	-	5	4	8	9	11
Current Income Taxes Payable	55	536	484	671	428	427
Other Current Liabilities	371	19	19	26	28	23
Total Current Liabilities	2,664	2,721	2,829	3,339	3,369	3,151
Long-Term Debt	757	840	818	623	1,013	1,280
Long-Term Leases	-	14	3	8	16	26
Other Long-Term Liabilities	28	15	16	14	19	18
Total Liabilities	3,449	3,590	3,666	3,984	4,417	4,475

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	495	495	495	495	495	495
Additional Paid-In Capital	400	400	400	400	400	400
Retained Earnings	8,527	8,676	8,414	7,920	7,506	7,368
Treasury Stock	-1,826	-1,826	-1,826	-1,826	-1,826	-1,826
Comprehensive Income & Other	31	31	32	33	21	8
Shareholders' Equity	7,627	7,776	7,515	7,022	6,596	6,445
Total Liabilities & Equity	11,076	11,366	11,181	11,006	11,013	10,920

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	2,112	2,268	2,051	2,142	2,755	2,933
Net Cash (Debt)	323	510	944	597	-239	-415
Net Cash Growth	-54.05%	-45.98%	58.12%	-	-	-
Net Cash Per Share	11.24	17.75	32.86	20.78	-8.32	-14.45
Filing Date Shares Outstanding	28.73	28.73	28.73	28.73	28.73	28.73
Total Common Shares Outstanding	28.73	28.73	28.73	28.73	28.73	28.73
Working Capital	4,097	4,307	4,156	3,391	3,269	3,421
Book Value Per Share	265.49	270.67	261.59	244.43	229.60	224.34
Tangible Book Value	7,598	7,754	7,503	7,009	6,587	6,430
Tangible Book Value Per Share	264.48	269.91	261.17	243.97	229.29	223.82

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 5, 2026

Data Sources Report a data error